Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
Quinton Biotech Labs [Automatic translation follows] We are the first biotechnology company to offer the possibility of taking care of your health with seawater specialties. Quinton Laboratories are pharmaceutical laboratories dedicated exclusively to the preparation of cold microfiltered seawater. Direct heirs of the French biologist and physiologist René Quinton, this laboratory is distinguished by scrupulously following the original method of its founder, which we have been able to update according to the European pharmacopoeia. We are at the complete disposal of health professionals or the general public to satisfy their desires for knowledge about Marine Therapeutics and the use of Quinton specialties. Quinton … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 65 | |
Haven House Children's Hospice Our hospice cares for seriously ill children, we are a vital lifeline for families going through the toughest of times. Haven House Children’s Hospice believes that no family should have to face alone the difficulties of looking after a child with a life-limiting condition. We provide a range of services to the child and their families to support them through the most difficult circumstances imaginable. We offer planned respite, short break and end-of-life care, as well as services designed to improve emotional and physical wellbeing, in the hospice and in our local community. Our support includes music therapy, therapeutic yoga, … Type: SMB Activities: healthtech kidtech Technologies: Synthetic Biology | 1 | 0 | 1 | 79 | |
Inmunotek Innovating and sharing ideas since 1992 INMUNOTEK is a pharma company which researches, develops, manufactures and distributes therapeutic vaccines in the fields of allergy, infectious diseases and cancer. In addition, the company develops, manufactures and sells medical devices. INMUNOTEK was founded in 1992 with the mission of improving the quality of life of patients and providing value to healthcare professionals, by creating innovative, safe and effective products. INMUNOTEK's products are sold in both Spain and in more than 50 other countries around the world through our subsidiaries, sales offices and exclusive distributors. Our two production centres are based in the … Type: SMB Activities: deeptech biotech healthtech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 327 | |
Medical Design & Outsourcing Medical Design & Outsourcing focuses on all aspects of the design, development and manufacturing of medical devices. Medical Design & Outsourcing covers the technical advances fueling innovation in the design, development and contract manufacturing aspects of medical devices and equipment. In addition to posting several staff-written stories per day, we publish an edition seven times a year with themes such as leadership in medtech, enabling technologies, hot topics, contract manufacturing, women in medtech, the medical device equipment handbook and the Big 100, (an in-depth look at the largest 100 medtech/medical device companies in the world). The editions include staff-written features … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 9 | 0 | 6 | 4 | |
The Jackson Laboratory Cancer. Diabetes. Alzheimer’s. Heart disease. JAX leads the search to cure diseases rooted in our DNA. OVERVIEW • The Jackson Laboratory is an independent, 501(c)3 nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine. • Our mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. • We are a global team of nearly 3,000 people at 11 locations in Maine, Connecticut, California, Japan and China, and in remote locations around the world. • With a 2023 operating budget of $628M, JAX has substantial impact … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 | 2 | 2,213 | |
MedXCell SA The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 8 | |
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) Striving to ensure the best possible care and outcome for all children and adolescents with cancer in Europe. The European Society for Paediatric Oncology (SIOP Europe or SIOPE), is the only pan-European organisation representing all professionals working in the field of childhood cancers. With more than 2500 members across 35 European countries, SIOPE is leading the way to ensure the best possible care and outcomes for all children and adolescents with cancer in Europe. SIOPE’s mission is to increase both the cure rate and the quality of cure for children with cancers. As such, SIOPE’s aim is to support education … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology | 11 | 1 | 10 | 35 | |
New England Biolabs be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 5 | 9 | 750 | |
SteriPack Group Contract Design & Manufacturing Services | Pharma | Medical Devices | Orthopedics SteriPack is a contract design & manufacturing organization (CDMO) serving the healthcare industry. We work with some of the best known pharmaceutical, medical device and orthopedic organizations globally, from our locations across the USA, Europe and Asia. We're known for our outstanding client service, our flexibility and our ability to innovate and tailor solutions to take products to market quickly, safely and effectively. Whether we're helping you overcome challenges at specific stages of the product journey, or supporting you right through from product concept to market reality, we're … Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 2 | 395 | |
Syntara Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fibrosis and inflammation. Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Syntara is managing three phase 2 clinical studies in diseases of high unmet need with a further two potential phase 1c/2 studies being evaluated for 2024. Lead candidate SNT‐5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 58 | |
OpGen, Inc. Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship. About Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). Together we improve patient … Type: SMB Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 6 | 0 | 2 | 48 | |
BioMelbourne Network Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 18 | 2 | 18 | 22 | |
SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 5 | 7 | 40 | |
Fluofarma Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
NORAKER [Automatic translation follows] Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine, is dedicated to promoting bone reconstruction for patients who have undergone orthopedic or dental surgery. Spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company is committed to close and regular collaboration with surgeons and healthcare professionals to always better meet the requirements of the medical community. NORAKER products are used in orthopedic, spinal, CMF, ENT and … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 21 | 5 | 11 | 41 | |
AB Science AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 0 | 87 | |
LAPROVET [Automatic translation follows] Their health is also ours. LAPROVET is a leading French veterinary laboratory in sub-Saharan Africa and with strong growth in Southeast Asia and the Middle East. With our ambition to contribute to the long-term development of livestock sectors, the company has grown and developed by putting its values at the forefront: - Quality with the manufacture of veterinary medicines according to current European standards (GMP, GLP and GDP). - Education for local support and ongoing training of breeders in the field thanks to an efficient network of national technical representatives The nature of human relationships within our … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 1 | 26 | |
GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 5 | 5 | 192 | |
Vect-Horus Enhancing the transport of therapeutic and imaging agents using versatile and flexible targeting technologies VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 24 | 6 | 10 | 48 | |
Scemed by Winncare [Automatic translation follows] Improving the lives of people who are losing their autonomy and those who care for them. A major player in the medical equipment market in France, Scemed by Winncare is a specialist in hygiene, transfer and disinfection equipment in healthcare facilities. SCEMED develops innovative concepts that provide real solutions for improving patient care and improving the working conditions of healthcare staff. Our worlds: - HYGIENE: medicalized bathtubs, well-being, therapeutic - SHOWER EQUIPMENT: shower trolleys and chairs, bariatric range - TRANSFER: ceiling rail system, verticalizers, mobile patient lifts, harnesses - DISINFECTION: washer-disinfector, layout and storage solutions Our product … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 7 | 3 | 5 | 40 | |
Laboratoires BIOTIC Phocea [Automatic translation follows] Innovative solutions in dermo-pigmentation and cosmetics Founded in 1999 by Doctor Tiziano, BIOTIC Phocea Laboratories have recognized expertise in restorative and corrective dermopigmentation. Based in Marseille, we specialize in the design and manufacture of high-quality sterile pigments, meeting the strict standards of CEIIb medical devices (BIOCHROMADERM®, BIOCHROMAEYES®, RADSAFE®) as well as the latest European recommendations (REACH) in permanent makeup. Our expertise extends from medical dermopigmentation, used for corrective or restorative procedures (scars, post-surgical reconstruction, etc.), to aesthetic pigmentation (eyebrows, lips, eyes, scalp, etc.). Our dermopigmentation training center welcomes novice and expert dermopigmentation trainees. This center offers an … Type: SMB Activities: cosmetics healthtech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 28 | |
ACM Pharma [Automatic translation follows] Your specialized partner in contamination control Laboratory for microbiological analysis of health products. Located in the heart of the Centre Val de Loire region near the major pharmaceutical and cosmetic centers, the microbiology laboratory, run by specialized pharmacists and scientists, brings its know-how and more than 10 years of experience to the service of the pharmaceutical industries, manufacturers of medical and cosmetic devices. Analyses carried out within the laboratory: Microbial contamination, endotoxins, sterility testing, bacterial identification, antibiotics, water analysis, challenge tests, testing of antiseptics and disinfectants. Microbiology laboratory, Monitoring of clean rooms, Challenge test, Bacterial identification, Endotoxin, … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 64 | |
GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 5 | 20 | 154 | |
Scaleo Medical SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 0 | 2 | 40 | |
THEYA Healthcare Made With Empathy THEYA Healthcare designs and manufactures garments that promote healing, offer exceptional comfort and functionality, and look beautiful. Our bras and briefs are clinically proven to have a positive impact on body image, improve quality of life and help heal and alleviate pain. Founded in 2015, Theya Healthcare was originally established to fulfill an unmet need in women's breast cancer health. Our female designers created the original patented bamboo post-surgery bra. To this day, we remain the only post-surgery bra, clinically proven to help women heal and feel better faster after breast cancer surgery. We use the finest … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 0 | 2 | 2 | |
SNIPR Biome - A CRISPR Company Clinical CRISPR and Gene Therapy of the Microbiome Company We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 42 | |
Galecto, Inc. Clinical stage fibrosis and cancer treatments Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 3 | 18 | |
Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology | 10 | 0 | 9 | 187 | |
Beanfields The Positively Addicting Bold Bean Chip. Beanfields is on a mission to inspire the world to upgrade their snacking habits with crunchy, mouth-watering BEAN-BASED chips that are POSITIVELY ADDICTING and deeply nutritious. Every bag of Beanfields chips is full on flavor, packed with protein and fiber, Non-GMO, gluten free, and vegan. Finally, an addiction you can feel good about. Beanfields are currently sold throughout all 50 states, Canada, and other countries. We have a unique social impact partnership with Homeboy Industries, the largest and preeminent gang rehabilitation and re-entry program in the world. Bean and Rice Chips, Gluten-Free Snacks, Vegan … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 3 | 0 | 1 | 3 | |
Promobot Corp. Service robots for business Promobot is the largest service robotics manufacturer in Europe. We work in the fields of mechatronics, AI, and neural networks. Our developments include autonomous navigation, dialogue systems, manufacturing of artificial skin and muscles. Promobot creates humanoid and service robots, while also engaging with human-machine interaction as a whole. Promobot robots operate in 40 countries around the world. Their line of work includes interaction with people at events, customer assistance, management of internal systems, and patient assessment for hospitals. Robotics, AI, Hardware, Software, Industry, IT, and Engineering Type: Startup Activities: it services manufacturing Technologies: A.I. A.I. - Deep Learning Robotics Synthetic Biology | 5 | 1 | 3 | 31 | |
mymediks [Automatic translation follows] My medications, everywhere, on time, safely 🚀 mymediks has been the leader in specialized delivery of medications to individuals and healthcare professionals since 2016 and the 1st specialized network of healthcare delivery people. 🇫🇷 Thanks to our tools and know-how, we now support healthcare professionals in more than 12 French cities to deliver medications safely. 🧑💻 For more information: http://www.my-mediks.com Pharmacy, Medicines, Delivery, Health, Internet, Innovation, Startup, Business Developer, Transport, Patients, Transport, e-health, Pharmacy, and PDA Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
NanOlogy Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 9 | |
Impel Pharmaceuticals Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 47 | |
Viridian Therapeutics, Inc. Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 163 | |
Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 93 | |
Shockwave Medical Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 1,355 | |
Leuko Non-invasive white blood cell monitoring Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device. Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 3 | 1 | 15 | |
Pear Therapeutics The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 15 | 4 | 2 | 36 | |
Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 0 | 2 | 338 | |
Caribou Biosciences Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 | 4 | 165 | |
Sirenas Bringing you a new generation of health products inspired by marine biodiversity Over the last decade and working with experts and local communities, Sirenas has sustainably and ethically built one of the largest and most unique collections of marine organisms and plants from diverse ecosystems and geographies. From the deep sea to coral reefs and estuaries. We’ve run these samples through cutting edge and proprietary chemical extraction and analytics, and tested each one in over 70 in-vitro biological assays relevant to human health. The result is the largest repository of information connecting the unchartered chemistry of marine organisms to applications … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 11 | |
BIOLIFE4D Build a Heart. Save a Life. Pioneered by accomplished business leaders, guided by world-class biomedical and life science experts, and financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death worldwide. Leveraging advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation, this biotech company is committed to optimizing the process and technology around viable human organ replacement, and making it a safe, accessible, commercially viable, and cost-effective reality. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 7 | |
Freenome Outpacing cancer starts with early detection Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 11 | 4 | 5 | 432 | |
Ligandal Ligandal is developing precision molecular therapeutics and targeted delivery technologies. Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, … Type: Startup Activities: biotech deeptech healthtech nanotech Technologies: Synthetic Biology | 2 | 1 | 1 | 12 | |
ECOVO Project manager within medical device and pharmaceutical industry. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
RedDress Ltd. Healing is in Our Blood RedDress, a private medical device company, developed a ground-breaking, advanced wound care solution based on a patented technology using a patient's own blood to harness body's natural process to heal wounds. The company based in Israel, was founded in 2009 by Dr. Igal Kushnir, MD and Alon Kushnir and is focused on developing effective solutions that improve patient outcomes. RedDress management has vast experience in bringing breakthrough medical ideas to successful commercialization. wound care, wound healing, tissue repair, chronic ulcers, diabetic foot ulcers, pressure ulcer , venous ulcers, burns, and wound dressing Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 40 | |
Mi Terro® Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, … Type: Startup Activities: agritech biotech cleantech deeptech greentech Technologies: Bio sourced materials New Materials Synthetic Biology | 11 | 2 | 7 | 13 | |
Tongue Lab Better Breath, Better Sleep Our tongue says a lot about our health. Lingual dysfunctions are a major cause of problems as diverse as chronic snoring, obstructive sleep apnea (OSA), mouth breathing, malocclusion (misalignment of the teeth), bruxism (teeth grinding and jaw clenching), temporomandibular joint dysfunction and atypical swallowing. Tongue Lab created the TRP (Tongue Right Positioner), a patented, oral medical device designed to reeducate the tongue and permanently restore its physiological functions, position and muscle tone. The TRP is worn on the upper teeth while we sleep for an average of six months only. By treating the lingual dysfunctions that … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 2 | 2 | 6 | |
Sysark [Automatic translation follows] Trust and innovation Sysark markets the world's first device for the preparation, mixing, storage and sampling of Tc99m radiopharmaceutical drugs. Type: Startup Activities: it services Technologies: Synthetic Biology | 8 | 1 | 4 | 12 | |
Les Frimeuses Un régal de légumineuses First of all, you may ask "What is Frimeuses?" Frimeuse : A person who takes a confident attitude in order to impress those around them... now you know who we are. Our idea? To create an aperitif product that is healthy, tasty, fresh and environmentally responsible! Sounds good, doesn't it? 🤤 This product is suitable for consumers who are concerned about their health and their environment! What is it? A range of healthy and gourmet aperitif spreads made from fermented legumes. Who are we? A team of 2 passionate, motivated and creative engineers. And that's not … Type: Startup Activities: foodtech Technologies: Synthetic Biology | 4 | 1 | 0 | 1 | |
Excellent® Producteur d’Alternatives végétales 🌱🍔 - Save the World, Change the Food 🌍 Excellent® est une entreprise qui propose des alternatives végétales BIO, Françaises, gourmandes et saines. > Excellent pour la planète 🌍 > Excellent pour vous 🌱 > Excellent tout court. 😋 Alt-Meat, BIO, Gastronomie, végétarien, Impact, Start-up, Proteins, Veggie, Foodtech, and PlantBased Type: Startup Activities: foodtech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
BIOPHTA Changing the lives of patients suffering from chronic eye diseases ! World Health Organization evaluates between 200 and 300 million, the number of people who are visually impaired by diseases against which pharmaceutical treatments are however existing. Many of these conditions have in common to cause permanent vision loss if they are not treated consistently. The lack of adherence to prescription eye drops is the #1 Unmet Medical need in Ophthalmology. Poor treatment Compliance and Adhesion leads to a worse progression of Eye Diseases. BIOPHTA wants to change the lives of patients suffering from chronic eye diseases by creating a … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 4 | 3 | 7 | |
Selenium Medical Intuitive Innovation for Infection Prevention We believe that innovation is the key to success in Medical Device Market. Innovation, creation & patient well-being are in our DNA, we dare to go further, whether single-handedly or in partnership with our customers, while thinking outside the box thanks to our specialization and expertise in the medical industry. We can offer you our know-how, specific skills and expertise in technical consultancy for your projects in clean room injection, surface treatment and sterile packaging of your medical devices, through our different divisions SELENIUM Injection, SELENIUM Surface Treatment and SELENIUM Packaging. In all our divisions, … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 12 | 1 | 10 | 48 | |
Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Computational Chemistry, Molecular Dynamics Simulation, Quantum Physics, Drug Discovery, Drug Design, Quantum Computing, Quantum Chemistry, and HPC Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 57 | 17 | 48 | 66 | |
Overseed Medical cannabis: from seed to purified pharmaceutical grade active ingredients Overseed is the first French biotech company to obtain its license from the ANSM to start its R&D process on cannabis production for pharmaceutical purposes. We are a Biotech which combines leading expertise in genetics, agronomy, organic chemistry and pharma with the ambition to have an expert knowledge on the production of therapeutic cannabis. We will produce GACP and GMP certified dried flowers, full spectrum extracts and purified pharmaceutical grade active ingredients for laboratories. Overseed's research and experimentation will answer patients and the health industry expectations to guarantee production sovereignty, … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 2 | 0 | 18 | |
MOTEN Technologies Preventing risks of MSD by measuring muscular effort. MOTEN Technologies is a startup founded in 2018 and centered around a mission : to preserve the health and performance of men and women whose muscles constitute a precious and irreplaceable capital. After a year of development, we have prototyped and manufactured in France the first measurement technology «listening» the sounds produced by the muscles, revealing their level of effort and fatigue in any situation. Today, we support companies in various sectors whose operators are exposed to the risks of occupational diseases and accidents related to physical activity. Our clients seek to … Type: Startup Activities: it services Technologies: Synthetic Biology | 29 | 6 | 20 | 10 | |
USC The official Twitter account of the University of Southern California. #USC | #FightOn Type: SMB Activities: deeptech Technologies: Synthetic Biology | 53 | 13 | 8 | N/A | |
MindMaze France [Automatic translation follows] Specialized in Therapeutic Video Games and Digital Medical Devices. We are specialized in Therapeutic Video Games and Digital Medical Devices. Co-founder of LabCom BRAIN e-NOVATION with the Brain and Spine Institute. Type: Startup Activities: games healthtech Technologies: Synthetic Biology | 18 | 0 | 18 | 3 | |
Kazia Therapeutics Limited Kazia Therapeutics (NASDAQ: KZIA) is developing innovative treatments for cancers with significant unmet need. Kazia Therapeutics Limited (NASDAQ: KZIA) is an oncology-focused drug development company. Our lead program is paxalisib, which is being developed to treat glioblastoma (GBM), the most common and aggressive form of primary brain cancer in adults. There are few treatment options for sufferers of GBM and around 65% of sufferers do not respond to currently available treatments. The condition affects around 133,000 people globally per annum and the potential addressable market is worth more than US$1 billion. Kazia’s drug paxalisib, commenced recruitment to GBM AGILE, a … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Gyros Protein Technologies Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPloreTM), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 4 | 132 | |
Aridis Pharmaceuticals Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 23 | |
Anatomics Quality Surgical Solutions Anatomics is a medical technology company that has been manufacturing high-quality medical devices, prosthetics and software solutions since 1995. Based in Melbourne Australia, Anatomics manufactures high quality patient specific implants for global distribution and in-licenses novel technology for Australian and New Zealand distribution. We strive to be recognised as a trusted and innovative provider of quality surgical products. Our mission is to work in partnership with healthcare professionals and medical device companies to provide the highest quality surgical products. We are a company of experienced and dedicated team members who strive for better surgical outcomes by initiating … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 91 | |
Point of Care Diagnostics Answers when you need them POCD are changing the way healthcare is delivered by sourcing the finest quality technology and brining it to Australia and New Zealand for all medical professionals to take advantage of. We are passionate about providing specialist services in near‐patient diagnostics and in‐vitro testing - including equipment and products tailored to the requirements of our customers. We have extensive experience in the following forms of equipment and product delivery: * Supply of laboratory consumables * Supporting corporate health programs * Running state‐wide public health initiatives * Implementing national pharmacy health programs The company began operations in … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Starpharma Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 4 | 75 | |
Research Institute of Molecular Pathology (IMP) A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter. The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology. Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology, and Microscopy Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 195 | |
Vienna BioCenter Vienna BioCenter is a leading life sciences campus in Europe, and we are hiring! Vienna BioCenter is a leading life sciences location in Europe, offering a unique combination of research, education and companies on a single campus: 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies. Over the last thirty years, the Vienna BioCenter has developed into one of the leading multi-disciplinary biomedical research centers in Europe and into the premier location for Life Sciences in Austria. Its institutions and companies are among the European leaders in their field and have been able to attract excellent scientists as … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 5 | 3 | 48 | |
g.tec medical engineering GmbH - NEVER STOP RECORDING Brain-Computer Interfaces & Neurotechnology g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery … Type: SMB Activities: healthtech biotech deeptech manufacturing Technologies: Affective Computing Synthetic Biology | 4 | 2 | 2 | 67 | |
LABORATOIRE POLIDIS [Automatic translation follows] Founded in 1986, Laboratoire POLIDIS is a human-sized company that has built its reputation in the field of medical devices. Its recognized expertise in the world of condoms also extends to pregnancy tests, ovulation tests, pain relief gels, food supplements as well as a wide range of anti-lice and nit products (shampoo, care cream, two-phase lotion and nit remover). Its status as a French manufacturer and the excellent reputation of its products make Laboratoire POLIDIS a privileged partner of the French Pharmacy. Innovation is the key to success. This is why we ask our teams for the … Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 18 | |
Hôpital Privé La Casamance [Automatic translation follows] 160 liberal practitioners with many specialties practice there thanks to a high-level technical infrastructure. In addition, multidisciplinary medical teams provide safe care for hospitalized or emergency patients 24 hours a day. 500 health professionals are present daily with patients. The establishment, organized into different activity centers, offers a complete care pathway that is broken down into diagnostic, therapeutic and rehabilitation care. Medical and interventional cardiology, Specialty medicine, Specialty surgery, Emergency medicine, Diagnostics, Perinatality, and Follow-up and rehabilitation care Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 230 | |
Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 2 | 13 | 84 | |
CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: SMB Activities: cosmetics biotech deeptech healthtech Technologies: Synthetic Biology | 12 | 5 | 7 | 2 | |
Proteus by Seqens Biocatalysis from Lab to Industrial Scale Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Proteus offers: - An exclusive and diversified microorganism collection (including micro-algae and thousands of bacteria and archaebacteria extremophiles strains) - 1,000 sequenced strains, combined with data mining tools, offering a unique pool of millions enzymes - Patented directed evolution technologies (EvoSightTM & L-ShufflingTM) to optimize enzymes performances - A multidisciplinary skilled team dedicated to custom bioprocess development for client’s applications - Seqens CDMO capabilities enabling large scale biocatalytic production of chemicals & pharmaceuticals … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 24 | |
NAVAN Transforming Cell Therapy Engineering NAVAN Technologies, Inc. is an enabling technology company commercializing a novel non-viral delivery platform to radically accelerate genetic engineering of human stem & primary cells. The patented NanoStraw technology provides direct intracellular access into hard-to-transfect stem & primary human cells for efficacious delivery of any cargo. By using a physical, non-perturbative mechanism for delivery, the challenges of viral-based cell manufacturing (time, cost and technical difficulties) are eliminated, resulting in fewer, faster operational steps. For more information on NAVAN, please visit www.navanbio.com. Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 7 | |
Paindrainer AB Complete RTM solution. Drug-free, medical device demonstrating improved quality of life and alleviation of chronic pain. Paindrainer® is the first drug-free, evidence-based digital medical device demonstrating improved quality of life and alleviation of chronic pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each user, a feature called 360° patient-centricity©. This feature is protected by a patent granted by the European Patent Office (EPO) for the unique proprietary platform that enables patient-centric chronic pain management. The Paindrainer® mobile application enables each user to manage their pain and provides guidance on how to achieve a personalized … Type: Startup Activities: healthtech Technologies: Synthetic Biology SaaS | 3 | 1 | 2 | 11 | |
Aktiia Blood Pressure Intelligence for Global Health At Aktiia, we're at the forefront of revolutionizing blood pressure management and comprehension globally. Harnessing cutting-edge AI-powered algorithms on top of over 300 million data points collected from more than 60,000 active users across the globe, we foster breakthroughs in hypertension comprehension and tailored patient care. Aktiia's CE-marked platform is currently available in seven European markets and approved as a medical device in 44 countries worldwide. And we continue to accelerate our efforts to achieve better health for the world. AI, hypertension, digital therapeutics, healthcare, blood pressure, and patient management Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 61 | |
Evelo Biosciences Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine. Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAXTM, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 1 | 22 | |
Science Exchange Science Exchange’s supplier orchestration platform harmonizes purchasing, supplier management, and payment processing. Science Exchange is the first purchasing and supplier orchestration platform for life sciences companies. We’re on a mission to streamline and modernize the way R&D organizations and suppliers work together. Our platform harmonizes purchasing, supplier management, and payment processing through one platform and digital marketplace. Whether using our network of 3,800 suppliers with established contracts or syncing existing ones, a simple intake process enables scientists to purchase the services and products they need while workflows and integrations guide them through approvals and compliance requirements. Science Exchange ensures supplier … Type: Startup Activities: it services Technologies: Synthetic Biology | 7 | 0 | 7 | 91 | |
Revolve Biotechnologies, Inc. Designing novel proteins, enzymes, and antibodies is limited by the problem of generating and screening vast mutational sequence space. Revolve addresses this problem with our patented library generation platform producing custom DNA libraries with unparalleled efficiency. The company has developed an ultra-affinity antibody discovery engine based on this library platform and has a pipeline of protein products in development. Custom mutagenesis libraries, Protein Engineering, Protein Libraries, and Antibody Engineering Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
AniCell Biotech Extending the ACTIVE life of Animals! AniCell is a biotech company that extends the ACTIVE life of animals with products generated non-invasively from the miracle of birth and used to accelerate regeneration of tissue and bone in injured animals. AniCell Video http://youtu.be/2H8qZLmNChY Cellular Biology, Regenerative Products, Stem Cells, Equine, Biotechnology, and Amnion Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Soylent A Simple Idea - Simplify Food, Make it Sustainable, Reduce Trade Offs Soylent means complete nutrition— innovative, science-based, and sustainable. We create our products to deliver complete plant based protein, essential nutrients, healthy fats, and slow-burning carbs in convenient and affordable formats that are both good for you and the planet. We carefully select high-quality ingredients to provide complete nutrition. Our company was founded on the principle of reducing trade-offs between nutrition, convenience, and sustainability and we continue to use these principles as guides in our product formulation and ingredient selection. Food Science, Food and Beverage, Nutrition, Health and Wellness, … Type: Startup Activities: agritech foodtech Technologies: Synthetic Biology | 19 | 5 | 7 | 42 | |
Maternova, Inc. The leading marketplace for cutting-edge medical innovations in maternal, newborn & reproductive health. Maternova, Inc. is the leading trusted resource for cutting edge medical innovations in women's health and newborn health. Governments, Ministries of Health, NGO's and healthcare professionals around the world partner with Maternova to procure trusted and rigorously tested pathbreaking technologies. We have a network of over 50,000 policymakers, clinicians, midwives, and thought leaders as part of our sphere of influence. To learn more about how your organization can work with Maternova, as either a client or manufacturer looking to commercialize your products, please contact us. Learn more: … Type: Startup Activities: healthtech deeptech biotech civictech Technologies: Synthetic Biology | 6 | 0 | 6 | 12 | |
PlateletBio Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 0 | 6 | 4 | |
Molekule Breathe better air in your home, office, or anywhere you work, play, laugh, feel, and live. Molekule is creating safer, healthier indoor environments worldwide, starting with our most essential resource: the air we breathe. Molekule's lineup of air purification solutions incorporates their patented photo electrochemical oxidation (PECO) technology, which surpasses traditional filters by effectively destroying a wide range of pollutants including VOCs, mold, bacteria, viruses, and allergens. These devices have undergone rigorous assessments and validations by third-party laboratories, earning FDA clearance as medical devices. It’s all part of Molekule’s vision of changing the world from the indoors out. By using … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 6 | 1 | 3 | 93 | |
Rheos Medicines [Automatic translation follows] Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 23 | |
Forest Devices, Inc. Improving the lives of stroke victims by developing tools for early and accurate neurologic assessment. Forest Devices is a medical device startup located in Pittsburgh, Pennsylvania. We are the creators of SignalNED, a fast, reliable, and accurate rapid EEG providing users clear qEEG results. Our mission is to create a better way to detect stroke and make informed decisions that directly lead to an improved quality of life for patients post-stroke and a decreased burden to the healthcare system and patient’s loved ones. Medical Devices Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 1 | 2 | 7 | |
EpiBone, Inc. EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 4 | 25 | |
MHW Care [Automatic translation follows] Lumix Laser - Cutting-edge technology - Unique, powerful & versatile lasers Exclusive distributor France for FISIOLINE. Cutting-edge technologies and effective therapeutic protocols for results from the first session. Medical device, laser, and Surgery Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
Warmilu Spread the warmth, save lives. Warmilu is a warming technology company manufacturing medical devices and products to save lives and provide comfort. We are currently warming over 8,000 infants born to over 35 hospitals based in 16 countries with partners including Doctors Without Borders, Relief for Africa Foundation, Rotary Club, the Hillman Accelerator, UCSF, the University of Michigan, and P&G among others. Together, we can spread lasting warmth to transform lives. Medical devices, Heat therapy, Heat technology, Phase-change technology, Personal care products, Social entrepreneurship, and Home healthcare Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 8 | 0 | 8 | 7 | |
Spiral Therapeutics delivering therapies for inner ear disorders We are a clinical stage company delivering therapies for inner ear disorders hearing loss, pharmaceuticals, Meniere's Disease, and drug delivery Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 10 | |
VisMed3D 3D Printing Data & Biomedical Consulting VisMed•3D is a leader in 3D Biomedical Printing, a technology that is redefining standards for patient care by improving access to personalized medicine. We are building global networks to connect the best physicians with the most advanced technology in additive manufacturing to increase the velocity of innovation in customized patient care. VisMed•3D is strategically selecting institutions to partner with and expand our network. We are seeking innovative healthcare leaders and early adopters that share our mission to ensure every patient and physician has access to the most advanced and precise surgical preparation tools. The … Type: Startup Activities: deeptech healthtech Technologies: 3D Printing Synthetic Biology | 4 | 0 | 1 | 3 | |
Organovo Holdings, Inc. Discovering drugs using highly customized human tissues as living, dynamic models of human biology and disease. We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We intend to fundamentally alter the drug discovery landscape by the development of novel therapies for disease which have a much higher chance of efficacy in the clinic focused on human primary cell 3D models of disease that more faithfully recapitulate disease processes. Learn more at www.organovo.com. 3D bioprinting, 3D printing, Drug discovery and … Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology | 0 | 0 | 0 | 34 | |
CERENOVUS Let's change the TRAJECTORY of stroke TOGETHER CERENOVUS, part of Johnson & Johnson MedTech, is an emerging leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. Medical Device, MedTech, Medical Technology, Stroke Care, Stroke Treatment, Neurovascular Care, Mechanical Thrombectomy, and Stroke Solutions Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 227 | |
Celmatix A preclinical-stage women’s health biotech focused uniquely on ovarian biology. Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com. Reproductive Biology and Medicine, Genomics, Bioinformatics, Biotech, Women's … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 8 | 1 | 5 | 24 | |
SQZ Biotechnologies Unlocking the full potential of cell therapies for patients around the world SQZ Biotechnologies is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies to benefit patients with cancer, autoimmune and infectious diseases. The company’s proprietary Cell Squeeze® technology offers the unique ability to deliver multiple biological materials into many patient cell types to engineer what we believe can be a broad range of potential therapeutics. Our goal is to create well-tolerated cell therapies that can provide therapeutic benefit for patients and improve the patient experience over existing cell therapy approaches. With accelerated production timelines under … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 1 | 3 | 18 | |
Circularis Biotechnologies Using circular RNA to control any gene, in any species, in any cell type. "Acquired by Ginkgo Bioworks in 2022" Control of any Gene in any Species or Cell Type Circularis has used the power of circular RNA to develop a novel method to study and regulate gene expression. This technology has enabled increased bio-therapeutic production, improved targeting of gene therapy, and optimized expression in poorly studied organisms. The elegant design and high throughput nature of this technology enables breakthrough solutions without prior knowledge of the regulatory elements or coding sequence. Gene Expression, Bioprocessing, Molecular Biology, Protein Expression, Drug Discovery, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Allevi by 3D Systems Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life. Allevi builds tools to design and engineer with life. Our 3D bioprinters and bioinks are used by leading researchers worldwide to find solutions to humanity's most difficult problems - to cure disease, to test novel drugs, to eliminate the organ waiting list, to build with life. Founded in 2014, our mission is to make it easy to design and engineer 3D tissues. We created our desktop 3D bioprinter to be the most versatile, powerful and easy-to-use bioprinter on the market. Since our humble beginnings, we have grown to … Type: Startup Activities: deeptech biotech healthtech Technologies: 3D Printing Synthetic Biology | 8 | 1 | 5 | 3 | |
Physidia Make People's Lives Better. Physidia, a company founded in 2011 in Angers, France, is today known for its expertise in home dialysis. Right from the start, the company has made innovation its principal mission, helping home patients to find back their comfort and freedom on a daily basis. Thanks to the medical and para-medical expert opin¬ion, Physidia’s engineering team was able to create the S3 monitor, 100% dedicated to performance and safety. The S3 monitor is a portable machine dedicated to daily hemodialysis, simple to use, functions securely, and is discreet in appearance. Its development is based on multidisciplinary knowledge—that … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 12 | 1 | 5 | 76 | |
OSCARE [Automatic translation follows] Together for our health OSCARE is the e-health solution for managing and organizing coordinated care pathways (ETP programs, HDJ/HDS, RAAC, SSR, etc.) for caregivers and their patients. OSCARE improves patient care by streamlining complex care pathways and making them actors in their health. Our digital service adapts to all pathologies or health themes: cancer, diabetes, obesity, maternity, Alzheimer's, Parkinson's, mental health, cardiology, pulmonology, tobaccology, pain management, etc. We meet a real national need in terms of prevention, diagnosis and health education. Come and discover our solution on www.os.care, or contact us for any questions at bonjour@os.care See … Type: Startup Activities: edtech healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 7 | |
Arterya The experts in the detection of the artery Normandy start-up based in Caen, we develop Blood'Up, a medical device that allows the instant detection of arteries. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 32 | 13 | 28 | 15 |